CT colonography screening remains widely underutilized

Although computed tomography colonography (CTC) screening is a quick, noninvasive and accurate method to screen for colorectal cancer, new data suggests that the tool is yet to be widely utilized. 

Based on the results of a survey completed by more than 13,000 respondents who were eligible for the cancer screening, less than 2% reported undergoing CTC. While the utilization rates did appear to steadily increase over the last decade, they still lagged behind expectations. 

“CTC is a minimally invasive screening examination with high sensitivity for the detection of colonic polyps,” corresponding author Brandon O’Connor, with the University of the Incarnate Word School of Osteopathic Medicine in San Antonio, Texas, and co-authors explained.  “Despite the proven benefits, CTC utilization remains low, and there is limited information about participation rates among underrepresented minority communities and the effects of sociodemographic factors on CTC utilization.” 

The team noted colorectal cancer mortality rates in racial and ethnic minority groups, citing prior research showing these subpopulations less likely to undergo screening compared to white and non-Hispanic individuals. However, the results of the survey suggest Hispanic and Black individuals are more likely to complete CTC screening than their white peers. 

“These results suggest that expanding access to CTC may represent a valid and potentially more accepted method to increase CRC screening rates for racial and ethnic minorities and reduce CRC disparities,” the authors wrote. 

The survey was deployed in 2019 to eligible participants between the ages of 50-75. A total of 13,709 individuals responded. Out of those participants, just 1.4% reported undergoing CTC screening. However, experts cited an increase in screening rates when participants were questioned about the timing of their exams, with nearly 40% of those who reported completing CTC screening doing so within a year of the survey. This trend continued for the years prior as well, with survey results revealing that 18.5% underwent the exam within 2 years of the questionnaire, 13.0% within the last 3 years and 7.8% within the last 5 years. 

CTC screening is expected to rise in the coming years as colorectal cancer communication initiatives increase and patients become more aware of its availability, the authors suggested. 

“Not only is CTC preferable for patients, but it may provide a more accessible option for patients,” the experts noted. “CTC can help address some of the CRC screening disparities, especially if used in conjunction with screening modalities, by giving patients choice, increasing convenience, and improving access.” 

The full research can be viewed in the Journal of the American College of Radiology

Related cancer screening content: 

Stratifying patients by risk of poor outcomes could reduce overtreatment of lung cancer

AI-based mammo screening protocol reduces radiologist workload by 62%

Experts highlight 'suboptimal' rates of CMS-required shared decision making encounters prior to LDCT

'Surprising' decline in annual screening among breast cancer survivors has experts concerned

Individualized communications increase colorectal cancer screening completion

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.